MOLECULAR BIOLOGY OF THE APOA-II GENE
MOLECULAR BIOLOGY OF THE APOA-II GENE
批准号:
4694569
负责人:
KL LACKNER
金额:
$0.0万
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:
至
关键词:
abetalipoproteinemias apolipoproteins blood lipoprotein metabolism cellular pathology child (0-11) electrofocusing genetic manipulation human subject isoelectric point lipoprotein disorder liver cells lymph messenger RNA molecular biology nucleic acid sequence plasma sialate structural genes tissue /cell culture
中文摘要
点击翻译按钮获取中文摘要
英文摘要
The entire nucleic acid sequence of the human apoA-II gene has been
determined. The structure of the apoA-II gene is similar to that of other
apolipoproteins, like apoA-I, apoE, and apoC-III. The apoA-II gene
consists as the aforementioned genes of three introns and four exons. The
position of the introns is similar in all four genes. Promoter regions as
well as a possible Z-DNA element have been identified. The knowledge of
the structure of the gene will allow to study the expression in more detail.
To better understand the processing of apoA-II its isoforms have been
analyzed in human thoracic duct lymph and plasma as well as in culture
media from normal hepatocytes and the hepatoma cell line HepG2. ProapoA-II
and several isoforms of apoA-II including sialylated forms were
identified. ProapoA-II has a strikingly basic pI of 6.79 which is caused
by three additional positively charged residues as compared to mature
apoA-II. The major mature isoform has a pI of 4.90. The sialoforms are
more acidic and have a slightly higher apparent molecular weight. The
isoform pattern in several dyslipidemias is different from the normal
control. The reason for this variability is not yet fully understood.
The apoB-100 gene and mRNA have been analyzed in normal subjects and
abetalipoproteinemic (ABL) patients. The apoB gene is present in ABL and
not structurally different from normal controls as determined by Southern
blot analysis. The apoB-100 mRNA in ABL is of the same size as the normal
mRNA, but its concentration is reduced. The absence of apoB from the
plasma of ABL-patients, however, cannot be explained by this reduction. We
conclude that the defect in ABL is post-translational and additional
studies to characterize the defect are being undertaken.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
海外基金